Delisting risk
GT Biopharma (GTBP)
Developer of natural-killer-cell engagers for cancer and autoimmune disease.
$0.2833
At close−0.01 (−1.94%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
in 71 days
EPS estimate
−$0.10
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.66−$0.76−$0.55−$0.83−$2.22−$0.11−$0.12Pending
Estimate−$1.55−$0.64−$0.68−$0.38−$0.22−$0.08−$0.08−$0.10
Surprise−7.1%−18.8%+19.1%−118.4%−909.1%−37.5%−50.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.10 | — | — |
| Aug 2026 | −$0.08 | −$0.12 | −50.0% |
| Aug 2026 | −$0.08 | — | — |
| May 2026 | −$0.08 | −$0.11 | −37.5% |
| Mar 2026 | −$0.22 | −$2.22 | −909.1% |
| Nov 2025 | −$0.38 | −$0.83 | −118.4% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Apr 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Apr 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | — | — | — |
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.10 | — | — | — | — | — | — |
| Aug 14, 2026 | −$0.08 | −$0.12 | −50.0% | — | — | — | −0.5% |
| Aug 13, 2026 | −$0.08 | — | — | — | — | — | — |
| May 15, 2026 | −$0.08 | −$0.11 | −37.5% | — | — | — | −7.5% |
| Mar 2, 2026 | −$0.22 | −$2.22 | −909.1% | — | — | — | +0.6% |
| Nov 14, 2025 | −$0.38 | −$0.83 | −118.4% | — | — | — | −25.3% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Feb 21, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 4, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Oct 31, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 23, 2021 | |||||||
| May 17, 2021 | |||||||
| Apr 16, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 27, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 11, 2017 | |||||||
| Apr 28, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 10, 2016 | |||||||
| May 13, 2016 | |||||||
| Mar 30, 2016 | — | — | — | — | — | — | — |
| Nov 13, 2015 | |||||||